{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:50:37Z","timestamp":1792504237899,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.jaac.2011.05.011","type":"journal-article","created":{"date-parts":[[2011,7,14]],"date-time":"2011-07-14T16:01:18Z","timestamp":1310659278000},"page":"749-762.e39","source":"Crossref","is-referenced-by-count":107,"title":["Pharmacologic Treatments for Pediatric Bipolar Disorder: A Review and Meta-Analysis"],"prefix":"10.1016","volume":"50","author":[{"given":"Howard Y.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona P.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Yvonne","family":"Woodworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayna M.","family":"Yorks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter R.","family":"Petty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet R.","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen V.","family":"Faraone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Biederman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2011.05.011_bib1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0006-3223(00)00911-2","article-title":"Pediatric mania: a developmental subtype of bipolar disorder?","volume":"48","author":"Biederman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archpsyc.63.2.175","article-title":"Clinical course of children and adolescents with bipolar spectrum disorders","volume":"63","author":"Birmaher","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"suppl 7","key":"10.1016\/j.jaac.2011.05.011_bib3","first-page":"21","article-title":"Prepubertal and early adolescent bipolar I disorder: review of diagnostic validation by Robins and Guze criteria","volume":"66","author":"Geller","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4088\/JCP.08m04994yel","article-title":"Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood","volume":"71","author":"Post","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.biopsych.2004.01.022","article-title":"Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"55","author":"Perlis","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archpsyc.1997.01830160049008","article-title":"The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents","volume":"54","author":"Verhulst","year":"1997","journal-title":"Arch Gen Psychiatry"},{"issue":"3 Pt 2","key":"10.1016\/j.jaac.2011.05.011_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1399-5618.2000.20309.x","article-title":"Bipolar disorder during adolescence and young adulthood in a community sample","volume":"2","author":"Lewinsohn","year":"2000","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2011.05.011_bib8","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1017\/S1461145708009231","article-title":"Treatment of bipolar disorder: a systematic review of available data and clinical perspectives","volume":"11","author":"Fountoulakis","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00213-006-0569-y","article-title":"Psychopharmacology of pediatric bipolar disorder: a review","volume":"191","author":"Smarty","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jaac.2011.05.011_bib10","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJMp1003175","article-title":"Pediatric mental health care dysfunction disorder?","volume":"362","author":"Parens","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaac.2011.05.011_bib11","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMc1007166","article-title":"Pediatric mental health care dysfunction disorder?","volume":"363","author":"Biederman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaac.2011.05.011_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archpsyc.61.5.459","article-title":"Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype","volume":"61","author":"Geller","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-5618.2010.00798.x","article-title":"Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials","volume":"12","author":"Correll","year":"2010","journal-title":"Bipolar Disord"},{"issue":"suppl","key":"10.1016\/j.jaac.2011.05.011_bib14","doi-asserted-by":"crossref","first-page":"177S","DOI":"10.1097\/00004583-199710001-00011","article-title":"Practice parameters for the assessment and treatment of children and adolescents with schizophrenia","volume":"36","author":"McClellan","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib15","first-page":"55","article-title":"Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia","volume":"4","author":"Bishop","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.jaac.2011.05.011_bib16","first-page":"87","article-title":"Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder","volume":"60","author":"Hamrin","year":"2008","journal-title":"Minerva Pediatr"},{"key":"10.1016\/j.jaac.2011.05.011_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1399-5618.2006.00313.x","article-title":"Pediatric bipolar disease: current and future perspectives for study of its long-term course and treatment","volume":"8","author":"Strober","year":"2006","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2011.05.011_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004583-200006000-00009","article-title":"Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder","volume":"39","author":"Kowatch","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1089\/cap.2006.16.336","article-title":"A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder","volume":"16","author":"Pavuluri","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/01.chi.0000155981.83865.ea","article-title":"Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder","volume":"44","author":"Findling","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib21","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/00004583-200210000-00011","article-title":"A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania","volume":"41","author":"Delbello","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.chi.0000194567.63289.97","article-title":"A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania","volume":"45","author":"DelBello","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/cap.2009.0042","article-title":"Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder","volume":"19","author":"Wozniak","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.biopsych.2005.03.019","article-title":"Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children","volume":"58","author":"Biederman","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jaac.2011.05.011_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jaac.2011.05.011_bib29","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/00004583-200112000-00016","article-title":"Adjunctive antipsychotic treatment of adolescents with bipolar psychosis","volume":"40","author":"Kafantaris","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib30","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/01.CHI.0000070247.24125.24","article-title":"Lithium treatment of acute mania in adolescents: a large open trial","volume":"42","author":"Kafantaris","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00004583-199802000-00009","article-title":"Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency","volume":"37","author":"Geller","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib32","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.chi.0000129223.89433.74","article-title":"Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study","volume":"43","author":"Kafantaris","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/cap.2008.0162","article-title":"A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder","volume":"20","author":"Joshi","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/cap.1994.4.263","article-title":"Open trial of valproate in the treatment of adolescent mania","volume":"4","author":"West","year":"1994","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004714-199504000-00006","article-title":"The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial","volume":"15","author":"Papatheodorou","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib36","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/00004583-200210000-00012","article-title":"An open-label trial of divalproex in children and adolescents with bipolar disorder","volume":"41","author":"Wagner","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1399-5618.2005.00204.x","article-title":"Divalproex sodium for pediatric mixed mania: a 6-month prospective trial","volume":"7","author":"Pavuluri","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2011.05.011_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/cap.2008.0106","article-title":"Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder","volume":"19","author":"Redden","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/CHI.0b013e31819c55ec","article-title":"A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents","volume":"48","author":"Wagner","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1755-5949.2009.00121.x","article-title":"A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder","volume":"16","author":"Biederman","year":"2010","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jaac.2011.05.011_bib41","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/appi.ajp.163.7.1179","article-title":"A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents","volume":"163","author":"Wagner","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/cap.2006.0024","article-title":"Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial","volume":"17","author":"Tramontina","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.chi.0000159151.75345.20","article-title":"A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder","volume":"44","author":"Delbello","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib44","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1017\/S1092852900021519","article-title":"An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder","volume":"12","author":"Biederman","year":"2007","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jaac.2011.05.011_bib45","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1017\/S1092852900015443","article-title":"Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit\/hyperactivity disorder: an open clinical trial","volume":"12","author":"Tramontina","year":"2007","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jaac.2011.05.011_bib46","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.08m04726","article-title":"Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit\/hyperactivity disorder: a pilot randomized clinical trial","volume":"70","author":"Tramontina","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib47","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4088\/JCP.09m05164yel","article-title":"Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study","volume":"70","author":"Findling","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/10445460152595568","article-title":"A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder","volume":"11","author":"Frazier","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib49","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1176\/appi.ajp.2007.06111932","article-title":"Olanzapine versus placebo in the treatment of adolescents with bipolar mania","volume":"164","author":"Tohen","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-244X-9-4","article-title":"Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine","volume":"9","author":"Duffy","year":"2009","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cap.2005.15.311","article-title":"An open-label trial of risperidone in children and adolescents with bipolar disorder","volume":"15","author":"Biederman","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib52","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1399-5618.2009.00750.x","article-title":"Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study","volume":"11","author":"Haas","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2011.05.011_bib53","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1399-5618.2007.00450.x","article-title":"A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder","volume":"9","author":"Biederman","year":"2007","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2011.05.011_bib54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1399-5618.2010.00799.x","article-title":"Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder","volume":"12","author":"Gracious","year":"2010","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2011.05.011_bib55","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.euroneuro.2006.11.006","article-title":"Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial","volume":"17","author":"Wozniak","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib56","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0006-3223(03)00067-2","article-title":"Combination pharmacotherapy in children and adolescents with bipolar disorder","volume":"53","author":"Kowatch","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib57","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/01.CHI.0000046893.27264.53","article-title":"Combination lithium and divalproex sodium in pediatric bipolarity","volume":"42","author":"Findling","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.chi.0000189135.05060.8a","article-title":"Combination lithium and divalproex sodium in pediatric bipolar symptom re-stabilization","volume":"45","author":"Findling","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"suppl 1","key":"10.1016\/j.jaac.2011.05.011_bib59","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.jad.2004.05.017","article-title":"Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania","volume":"82","author":"Pavuluri","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jaac.2011.05.011_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1399-5618.2006.00276.x","article-title":"Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials","volume":"8","author":"Kushner","year":"2006","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2011.05.011_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005171.pub2","article-title":"Oxcarbazepine in the maintenance treatment of bipolar disorder","volume":"1","author":"Vasudev","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaac.2011.05.011_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1399-5618.2004.00098.x","article-title":"Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD","volume":"6","author":"Marangell","year":"2004","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2011.05.011_bib63","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4088\/JCP.v67n0401","article-title":"Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials","volume":"67","author":"Perlis","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib64","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1176\/ajp.149.12.1633","article-title":"Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania","volume":"149","author":"McElroy","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib65","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.chi.0000220851.94392.30","article-title":"Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents","volume":"45","author":"Correll","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib66","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies","volume":"161","author":"Correll","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S1461145709990344","article-title":"Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis","volume":"13","author":"Cruz","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1176\/appi.ajp.162.1.58","article-title":"Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium","volume":"162","author":"Scheffer","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib69","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/chi.0b013e31814b8d3b","article-title":"Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit\/hyperactivity disorder","volume":"46","author":"Findling","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib70","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/104454603322163844","article-title":"Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial","volume":"13","author":"Galanter","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib71","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/10445460050167287","article-title":"Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study","volume":"10","author":"Carlson","year":"2000","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib72","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1089\/cap.2008.0142","article-title":"Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic","volume":"19","author":"Potter","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_bib73","article-title":"How informative are open-label studies for youth with bipolar disorder?","author":"Biederman","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_bib74","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.biopsych.2005.07.019","article-title":"Neuropsychological functioning in youth with bipolar disorder","volume":"58","author":"Doyle","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004583-200006000-00009","article-title":"Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder","volume":"39","author":"Kowatch","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr2","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/00004583-200112000-00016","article-title":"Adjunctive antipsychotic treatment of adolescents with bipolar psychosis","volume":"40","author":"Kafantaris","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/01.CHI.0000070247.24125.24","article-title":"Lithium treatment of acute mania in adolescents: a large open trial","volume":"42","author":"Kafantaris","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1089\/cap.2006.16.336","article-title":"A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder","volume":"16","author":"Pavuluri","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_fr5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00004583-199802000-00009","article-title":"Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency","volume":"37","author":"Geller","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr6","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.chi.0000129223.89433.74","article-title":"Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study","volume":"43","author":"Kafantaris","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/01.chi.0000155981.83865.ea","article-title":"Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder","volume":"44","author":"Findling","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/cap.2008.0162","article-title":"A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder","volume":"20","author":"Joshi","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_fr9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/cap.1994.4.263","article-title":"Open trial of valproate in the treatment of adolescent mania","volume":"4","author":"West","year":"1994","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_fr10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004714-199504000-00006","article-title":"The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial","volume":"15","author":"Papatheodorou","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_fr11","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/00004583-200210000-00012","article-title":"An open-label trial of divalproex in children and adolescents with bipolar disorder","volume":"41","author":"Wagner","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr12","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/00004583-200210000-00011","article-title":"A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania","volume":"41","author":"Delbello","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1399-5618.2005.00204.x","article-title":"Divalproex sodium for pediatric mixed mania: a 6-month prospective trial","volume":"7","author":"Pavuluri","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2011.05.011_fr14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/cap.2008.0106","article-title":"Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder","volume":"19","author":"Redden","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_fr15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.chi.0000194567.63289.97","article-title":"A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania","volume":"45","author":"DelBello","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/CHI.0b013e31819c55ec","article-title":"A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents","volume":"48","author":"Wagner","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1755-5949.2009.00121.x","article-title":"A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder","volume":"16","author":"Biederman","year":"2010","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jaac.2011.05.011_fr18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/ajp.2006.163.7.1179","article-title":"A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents","volume":"163","author":"Wagner","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/cap.2006.0024","article-title":"Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial","volume":"17","author":"Tramontina","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_fr20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/cap.2009.0042","article-title":"Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder","volume":"19","author":"Wozniak","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_fr21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.chi.0000159151.75345.20","article-title":"A Pilot Controlled Trial of Topiramate for Mania in Children and Adolescents With Bipolar Disorder","volume":"44","author":"Delbello","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1017\/S1092852900021519","article-title":"An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder","volume":"12","author":"Biederman","year":"2007","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jaac.2011.05.011_fr23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1017\/S1092852900015443","article-title":"Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit\/hyperactivity disorder: an open clinical trial","volume":"12","author":"Tramontina","year":"2007","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jaac.2011.05.011_fr24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.08m04726","article-title":"Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit\/hyperactivity disorder: a pilot randomized clinical trial","volume":"70","author":"Tramontina","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr25","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4088\/JCP.09m05164yel","article-title":"Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study","volume":"70","author":"Findling","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/10445460152595568","article-title":"A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder","volume":"11","author":"Frazier","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_fr27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.biopsych.2005.03.019","article-title":"Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children","volume":"58","author":"Biederman","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr28","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1176\/appi.ajp.2007.06111932","article-title":"Olanzapine versus placebo in the treatment of adolescents with bipolar mania","volume":"164","author":"Tohen","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-244X-9-4","article-title":"Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine","volume":"9","author":"Duffy","year":"2009","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jaac.2011.05.011_fr31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cap.2005.15.311","article-title":"An open-label trial of risperidone in children and adolescents with bipolar disorder","volume":"15","author":"Biederman","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.05.011_fr32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1399-5618.2009.00750.x","article-title":"Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study","volume":"11","author":"Haas","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2011.05.011_fr33","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1399-5618.2007.00450.x","article-title":"A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder","volume":"9","author":"Biederman","year":"2007","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2011.05.011_fr35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1399-5618.2010.00799.x","article-title":"Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder","volume":"12","author":"Gracious","year":"2010","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2011.05.011_fr36","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.euroneuro.2006.11.006","article-title":"Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial","volume":"17","author":"Wozniak","year":"2007","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856711004448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856711004448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T20:20:38Z","timestamp":1560370838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856711004448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":106,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0890856711004448"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2011.05.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.722664135.793501344","asserted-by":"object"}]},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}